349 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
359 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
385 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
413 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
344 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
403 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
416 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
289 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
298 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
308 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
359 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
301 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
343 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
410 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
390 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
281 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
344 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
432 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
314 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
347 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
358 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 10:49
338 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 10:21
358 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 09:53
403 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 09:33
351 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 09:04
Point rules of this version Post Rebroadcast to the audience